Showing 1,301 - 1,320 results of 129,164 for search '(( i e decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 2.16s Refine Results
  1. 1301
  2. 1302
  3. 1303

    Analysis of ATP1A1 protein expression, blood pressure, heart rate and activity in heterozygous <i>ATP1A1<sup>+/−</sup></i> and wild-type male mice. by Victoria L. Herrera (383897)

    Published 2015
    “…(D) Mean heart rate ± sem (beats/min; BPM). (E) Mean activity ± sem (Counts/min) in <i>ATP1A1<sup>+/−</sup></i> (solid bars, n = 4) and wild-type (open bars, n = 5) male mice. * <i>P</i> < 0.03, ** <i>P</i> = 0.015 (two-tailed student <i>t</i>-test).…”
  4. 1304
  5. 1305
  6. 1306
  7. 1307
  8. 1308
  9. 1309

    VEGF and sFlt-1 mutant phenotypes. VEGF mutant overexpression of VEGF by RT-PCR and ELISA. sFlt-1 mutant expression of sFlt-1 by RT-PCR. by Christopher R. Schlieve (3179439)

    Published 2016
    “…(G) sFlt-1 mutant mice duodenum demonstrated a significant decrease in full length Flt-1 and sFlt-1 transcript at 21 days compared to littermates, suggesting a negative feedback response. …”
  10. 1310
  11. 1311
  12. 1312
  13. 1313

    (R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”
  14. 1314
  15. 1315
  16. 1316
  17. 1317
  18. 1318

    p35 siRNA knockdown decreased Cdk5 activity, diminished WT1 expression and viable cell numbers, but did not affect a cell apoptosis marker as detected by WB. by Ya-Li Zheng (454837)

    Published 2016
    “…A&B. Western blots show that p35 siRNA-transfected podocytes successfully decrease p35 expression (upper panel, lane 2) compared to the control siRNA cells (p<0.05), but did not affect cyclin I expression (3<sup>rd</sup> panel). …”
  19. 1319
  20. 1320